Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Clostridium difficile: an emerging pathogen in children.

Khalaf N, Crews JD, DuPont HL, Koo HL.

Discov Med. 2012 Aug;14(75):105-13. Review.

2.

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs ZG, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC.

JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.

PMID:
23780507
3.

The impact of Clostridium difficile on paediatric surgical practice: a systematic review.

Mc Laughlin D, Friedmacher F, Puri P.

Pediatr Surg Int. 2014 Aug;30(8):853-9. doi: 10.1007/s00383-014-3543-5. Epub 2014 Jul 10. Review.

PMID:
25008231
4.

Update on Clostridium difficile infection.

O'Donoghue C, Kyne L.

Curr Opin Gastroenterol. 2011 Jan;27(1):38-47. doi: 10.1097/MOG.0b013e3283411634. Review.

PMID:
21099432
5.

The emergence of Clostridium difficile infection among peripartum women: a case-control study of a C. difficile outbreak on an obstetrical service.

Unger JA, Whimbey E, Gravett MG, Eschenbach DA.

Infect Dis Obstet Gynecol. 2011;2011:267249. doi: 10.1155/2011/267249. Epub 2011 Jul 24.

6.

Recent trends in the epidemiology and treatment of C. difficile infection in children.

Sammons JS, Toltzis P.

Curr Opin Pediatr. 2013 Feb;25(1):116-21. doi: 10.1097/MOP.0b013e32835bf6c0. Review.

PMID:
23241874
7.

Clostridium difficile: a reemerging pathogen.

Calfee DP.

Geriatrics. 2008 Sep 1;63(9):10-21. Review.

PMID:
18763846
8.

A case-control study of community-associated Clostridium difficile infection.

Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN.

J Antimicrob Chemother. 2008 Aug;62(2):388-96. doi: 10.1093/jac/dkn163. Epub 2008 Apr 22.

PMID:
18434341
9.

Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings.

Durham DP, Olsen MA, Dubberke ER, Galvani AP, Townsend JP.

Emerg Infect Dis. 2016 Apr;22(4):608-16. doi: 10.3201/eid2204.150455.

10.

Clostridium difficile in children: a review of existing and recently uncovered evidence.

Morris O, Tebruegge M, Pallett A, Green SM, Pearson AD, Tuck A, Clarke SC, Roderick P, Faust SN.

Adv Exp Med Biol. 2013;764:57-72. Review.

PMID:
23654056
11.

[Clostridium difficile infection in children--experience of clinical centre in Bydgoszcz].

Duleba K, Smukalska E, Pawłowska M.

Przegl Epidemiol. 2012;66(1):67-71. Polish.

12.

Clostridium difficile infection in the community: are proton pump inhibitors to blame?

Freedberg DE, Abrams JA.

World J Gastroenterol. 2013 Oct 28;19(40):6710-3. doi: 10.3748/wjg.v19.i40.6710.

13.

Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection.

Galdys AL, Curry SR, Harrison LH.

Expert Rev Anti Infect Ther. 2014 Aug;12(8):967-80. doi: 10.1586/14787210.2014.920252. Epub 2014 May 22. Review.

PMID:
24848084
14.

Vital signs: preventing Clostridium difficile infections.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Mar 9;61(9):157-62. Erratum in: MMWR Morb Mortal Wkly Rep. 2015;64(35):988.

15.

Emergence of Clostridium difficile-associated disease in North America and Europe.

Kuijper EJ, Coignard B, Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control.

Clin Microbiol Infect. 2006 Oct;12 Suppl 6:2-18. Review.

16.

Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.

Dubberke ER, Butler AM, Hota B, Khan YM, Mangino JE, Mayer J, Popovich KJ, Stevenson KB, Yokoe DS, McDonald LC, Jernigan J, Fraser VJ; Prevention Epicenters Program from the Centers for Disease Control and Prevention.

Infect Control Hosp Epidemiol. 2009 Jun;30(6):518-25. doi: 10.1086/597380.

17.

Clostridium Difficile Colonization in Hematopoietic Stem Cell Transplant Recipients: A Prospective Study of the Epidemiology and Outcomes Involving Toxigenic and Nontoxigenic Strains.

Jain T, Croswell C, Urday-Cornejo V, Awali R, Cutright J, Salimnia H, Reddy Banavasi HV, Liubakka A, Lephart P, Chopra T, Revankar SG, Chandrasekar P, Alangaden G.

Biol Blood Marrow Transplant. 2016 Jan;22(1):157-63. doi: 10.1016/j.bbmt.2015.07.020. Epub 2015 Jul 26.

18.

Clostridium difficile surveillance trends, Saxony, Germany.

Burckhardt F, Friedrich A, Beier D, Eckmanns T.

Emerg Infect Dis. 2008 Apr;14(4):691-2. doi: 10.3201/eid1404.071023. No abstract available.

19.
20.

Clostridium difficile infection in HIV-seropositive individuals and transplant recipients.

Collini PJ, Bauer M, Kuijper E, Dockrell DH.

J Infect. 2012 Feb;64(2):131-47. doi: 10.1016/j.jinf.2011.12.003. Epub 2011 Dec 9. Review.

PMID:
22178989

Supplemental Content

Support Center